Open Interest and Volume Dynamics
On 25 Sep 2026, Fortis Healthcare’s open interest (OI) in derivatives rose sharply to 26,419 contracts from 21,021 the previous day, marking an increase of 5,398 contracts or 25.68%. This surge in OI was accompanied by a volume of 21,253 contracts, indicating robust trading activity. The futures value stood at ₹36,035.88 lakhs, while the options segment contributed a substantial ₹10,633.04 crores, culminating in a total derivatives value of approximately ₹36,970.97 lakhs.
The underlying stock price closed near ₹850, having opened with a gap down of 3.08% and touched an intraday low of ₹850.3. Notably, the stock has been on a three-day losing streak, shedding 5.1% over this period, and underperformed its hospital sector by 2.11% on the day. This price weakness contrasts with the rising open interest, suggesting that fresh positions are being established despite bearish price action.
Market Positioning and Potential Directional Bets
The increase in open interest amid falling prices often points to new short positions being built, as traders anticipate further downside. However, it can also indicate fresh long positions being opened in expectation of a reversal, especially if the volume is concentrated near the lower price range. In Fortis Healthcare’s case, the weighted average price of traded volumes was closer to the day’s low, implying that sellers dominated the session.
Further compounding this bearish sentiment is the stock’s position below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a sustained downtrend. Additionally, delivery volumes have declined sharply by 33.98% compared to the five-day average, reflecting waning investor participation in the cash segment. This reduced delivery volume suggests that the recent price moves are largely driven by speculative trading in derivatives rather than long-term accumulation.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Mojo Score and Analyst Ratings
Fortis Healthcare currently holds a Mojo Score of 44.0, categorised as a Sell rating, downgraded from Hold on 15 Sep 2026. This downgrade reflects deteriorating fundamentals and technical indicators, aligning with the recent price weakness and increased bearish positioning in derivatives. The company is classified as a mid-cap with a market capitalisation of ₹65,655 crores, operating within the hospital sector.
Given the stock’s underperformance relative to the sector’s 1-day return of -1.10% and the Sensex’s marginal gain of 0.09%, the negative momentum appears entrenched. The narrow intraday trading range of just ₹0.95 further indicates subdued investor conviction, with the weighted average price skewed towards the lower end of the day’s range.
Implications for Investors and Traders
The sharp rise in open interest combined with falling prices and declining delivery volumes suggests that market participants are increasingly positioning for further downside or volatility in Fortis Healthcare. Traders should be cautious of potential short-term price swings driven by speculative derivatives activity rather than fundamental improvements.
Investors may want to monitor the stock’s ability to reclaim key moving averages and observe changes in delivery volumes as a gauge of genuine investor interest. Until then, the prevailing technical and derivatives data point towards a cautious stance, with the risk of continued underperformance.
Fortis Healthcare Ltd or something better? Our SwitchER feature analyzes this mid-cap Hospital stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Conclusion: A Complex Derivatives Landscape
The recent surge in Fortis Healthcare’s open interest amid declining prices highlights a complex derivatives market landscape. While the increase in contracts signals heightened trader interest, the prevailing technical indicators and falling delivery volumes suggest a bearish bias. This scenario underscores the importance of integrating derivatives data with price action and fundamental analysis to fully understand market sentiment.
For investors, the current environment calls for prudence and close monitoring of key technical levels and volume patterns. The downgrade to a Sell rating by MarketsMOJO further emphasises the need for caution, as the stock faces headwinds in both the cash and derivatives markets.
Ultimately, the interplay between rising open interest and price weakness in Fortis Healthcare serves as a reminder that derivatives activity can both reflect and amplify underlying market trends, making it an essential factor in comprehensive stock analysis.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
